dinutuximab beta · Medicine question

How long should breastfeeding be discontinued during and after Qarziba (dinutuximab beta) treatment?

Name: How long should breastfeeding be discontinued during and after Qarziba (dinutuximab beta) treatment?
Published: 2026-11-08T01:45:06.144Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Breastfeeding should be discontinued throughout Qarziba (dinutuximab beta) treatment and for 6 months after the last dose.

Sources for this answer

Qarziba (Dinutuximab beta)Recordati UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 13Document updated 25 November 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about dinutuximab beta